Differences Between Familial and Sporadic Celiac Disease.
Celiac disease
Familial
HLA
Quality of life
Sporadic
Symptoms
Journal
Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
04
03
2020
accepted:
11
07
2020
pubmed:
25
7
2020
medline:
2
9
2021
entrez:
25
7
2020
Statut:
ppublish
Résumé
It is not known if genetic background, characteristics at diagnosis, physical and psychological well-being, and adherence to a gluten-free diet are comparable between patients with familial or sporadic celiac disease. These issues were investigated in a follow-up study. Altogether 1064 patients were analyzed for celiac disease-associated serology, predisposing HLA-DQ, and non-HLA genotypes. Medical data were collected from patient records and supplementary interviews. Current symptoms and quality of life were further evaluated with the Gastrointestinal Symptom Rating Scale (GSRS), the Psychological General Well-Being questionnaire (PGWB), and Short Form 36 (SF-36) questionnaires. Familial and sporadic groups differed (P < 0.001) in the reason for diagnosis and clinical presentation at diagnosis, familial patients being more often screen-detected (26% vs. 2%, P < 0.001) and having less often gastrointestinal (49% vs. 69%) and severe symptoms (47% vs. 65%). The groups were comparable in terms of histological damage, frequency of malabsorption, comorbidities, childhood diagnoses, and short-term treatment response. At the time of the study, familial cases reported fewer symptoms (21% vs. 30%, P = 0.004) and lower prevalence of all (78% vs. 86%, P = 0.007), neurological (10% vs. 15%, P = 0.013), and dermatological (9% vs. 17%, P = 0.001) comorbidities. Dietary adherence and GSRS scores were comparable, but familial cases had better quality of life according to PGWB and SF-36. High-risk genotype HLA-DQ2.5/DQ2.5 was more frequent among familial cases, and four non-HLA SNPs were associated with familial celiac disease. Despite the greater proportion of high-risk genotypes, familial cases had milder symptoms at presentation than did sporadic cases. Worse experience of symptoms and poorer quality of life in sporadic disease indicate a need for intensified support.
Sections du résumé
BACKGROUND
It is not known if genetic background, characteristics at diagnosis, physical and psychological well-being, and adherence to a gluten-free diet are comparable between patients with familial or sporadic celiac disease. These issues were investigated in a follow-up study.
METHODS
Altogether 1064 patients were analyzed for celiac disease-associated serology, predisposing HLA-DQ, and non-HLA genotypes. Medical data were collected from patient records and supplementary interviews. Current symptoms and quality of life were further evaluated with the Gastrointestinal Symptom Rating Scale (GSRS), the Psychological General Well-Being questionnaire (PGWB), and Short Form 36 (SF-36) questionnaires.
RESULTS
Familial and sporadic groups differed (P < 0.001) in the reason for diagnosis and clinical presentation at diagnosis, familial patients being more often screen-detected (26% vs. 2%, P < 0.001) and having less often gastrointestinal (49% vs. 69%) and severe symptoms (47% vs. 65%). The groups were comparable in terms of histological damage, frequency of malabsorption, comorbidities, childhood diagnoses, and short-term treatment response. At the time of the study, familial cases reported fewer symptoms (21% vs. 30%, P = 0.004) and lower prevalence of all (78% vs. 86%, P = 0.007), neurological (10% vs. 15%, P = 0.013), and dermatological (9% vs. 17%, P = 0.001) comorbidities. Dietary adherence and GSRS scores were comparable, but familial cases had better quality of life according to PGWB and SF-36. High-risk genotype HLA-DQ2.5/DQ2.5 was more frequent among familial cases, and four non-HLA SNPs were associated with familial celiac disease.
CONCLUSIONS
Despite the greater proportion of high-risk genotypes, familial cases had milder symptoms at presentation than did sporadic cases. Worse experience of symptoms and poorer quality of life in sporadic disease indicate a need for intensified support.
Identifiants
pubmed: 32705440
doi: 10.1007/s10620-020-06490-1
pii: 10.1007/s10620-020-06490-1
pmc: PMC8163668
doi:
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1981-1988Références
Mäki M, Mustalahti K, Kokkonen J, et al. Prevalence of celiac disease among children in Finland. N Engl J Med. 2003;348:2517–2524.
doi: 10.1056/NEJMoa021687
Myléus A, Ivarsson A, Webb C, et al. Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr. 2009;49:170–176.
doi: 10.1097/MPG.0b013e31818c52cc
Singh P, Arora A, Strand TA, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16:e2.
doi: 10.1016/j.cgh.2018.03.016
Pittschieler K, Gentili L, Niederhofer H. Onset of coeliac disease: a prospective longitudinal study. Acta Paediatr. 2007;92:1149–1152.
doi: 10.1111/j.1651-2227.2003.tb02475.x
Kurppa K, Salminiemi J, Ukkola A, et al. Utility of the new ESPGHAN criteria for the diagnosis of celiac disease in at: risk groups. J Pediatr Gastroenterol Nutr. 2012;54:387–391.
doi: 10.1097/MPG.0b013e3182407c6b
Oliveira A, Trindade E, Tavares M, Lima R, Terra M, Dias JA. Celiac disease in first degree relatives of celiac children. Arq Gastroenterol. 2012;49:204–207.
doi: 10.1590/S0004-28032012000300007
Singh P, Arora S, Lal S, Strand TA, Makharia GK. Risk of celiac disease in the first- and second-degree relatives of patients with celiac disease: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110:1539–1548.
doi: 10.1038/ajg.2015.296
Wessels MMS, de Rooij N, Roovers L, Verhage J, de Vries W, Mearin ML. Towards an individual screening strategy for first-degree relatives of celiac patients. Eur J Pediatr. 2018;177:1585–1592.
doi: 10.1007/s00431-018-3199-6
Bourgey M, Calcagno G, Tinto N, et al. HLA related genetic risk for coeliac disease. Gut. 2007;56:1054–1059.
doi: 10.1136/gut.2006.108530
Kårhus LL, Thuesen BH, Skaaby T, Rumessen JJ, Linneberg A. The distribution of HLA DQ2 and DQ8 haplotypes and their association with health indicators in a general Danish population. United Eur Gastroenterol J. 2018;6:866–878.
doi: 10.1177/2050640618765506
Liu E, Dong F, Barón AE, et al. High incidence of celiac disease in a long-term study of adolescents with susceptibility genotypes. Gastroenterology. 2017;152:e1.
Dubois PCA, Trynka G, Franke L, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet. 2010;42:295–302.
doi: 10.1038/ng.543
Trynka G, Hunt KA, Bockett NA, et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet. 2011;43:1193–1201.
doi: 10.1038/ng.998
Gutierrez-Achury J, Zorro MM, Ricaño-Ponce I, et al. Functional implications of disease-specific variants in loci jointly associated with coeliac disease and rheumatoid arthritis. Hum Mol Genet. 2016;25:180–190.
doi: 10.1093/hmg/ddv455
Lindfors K, Ciacci C, Kurppa K, et al. Coeliac disease. Nat Rev Dis Prim. 2019;5:3.
doi: 10.1038/s41572-018-0054-z
Hervonen K, Karell K, Holopainen P, Collin P, Partanen J, Reunala T. Concordance of dermatitis herpetiformis and celiac disease in monozygous twins. J Invest Dermatol. 2000;115:990–993.
doi: 10.1046/j.1523-1747.2000.00172.x
Celiac Disease. Current care guidelines, 2018. Working group set up by the Finnish Medical Society Duodecim and the Finnish Society of Gastroenterology. https://www.kaypahoito.fi . Accessed February 28, 2020.
Kivelä L, Kaukinen K, Lähdeaho ML, et al. Presentation of celiac disease in Finnish children is no longer changing: a 50-year perspective. J Pediatr. 2015;167:e1.
doi: 10.1016/j.jpeds.2015.07.057
Svedlund J, Sjödin I, Dotevall G. GSRS: a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33:129–134. https://doi.org/10.1007/252FBF01535722 .
doi: 10.1007/252FBF01535722
pubmed: 3123181
Dupuy HJ. The psychological general well-being (PGWB) index. In: Wenger NK, Mattson ME, Furburg CD EJ, eds. Assessment of quality of life in clinical trials of cardiovascular therapies. New York: Le Jacq Publishing; 1984.
Dimenäs E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl. 1996;221:8–13.
doi: 10.3109/00365529609095544
McHorney CA, Ware JE, Rachel Lu JF, Sherbourne CD. The MOS 36-item short-form health survey (SF–36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care.. 1994;32:40–66.
doi: 10.1097/00005650-199401000-00004
Monsuur AJ, de Bakker PIW, Zhernakova A, et al. Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms. PLoS ONE. 2008;3:e2270.
doi: 10.1371/journal.pone.0002270
Koskinen L, Romanos J, Kaukinen K, et al. Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations. Immunogenetics. 2009;61:247–256.
doi: 10.1007/s00251-009-0361-3
Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–575.
doi: 10.1086/519795
Rubio-Tapia A, Van Dyke CT, Lahr BD, et al. Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol. 2008;6:983–987.
doi: 10.1016/j.cgh.2008.04.008
Agardh D, Lee HS, Kurppa K, et al. Clinical features of celiac disease: a prospective birth cohort. Pediatrics. 2015;135:627–634.
doi: 10.1542/peds.2014-3675
Kivelä L, Kaukinen K, Huhtala H, Lähdeaho M-L, Mäki M, Kurppa K. At-risk screened children with celiac disease are comparable in disease severity and dietary adherence to those found because of clinical suspicion: a large cohort study. J Pediatr. 2017;183:e2.
doi: 10.1016/j.jpeds.2016.12.077
Nellikkal SS, Hafed Y, Larson JJ, Murray JA, Absah I. High prevalence of celiac disease among screened first-degree relatives. Mayo Clin Proc. 2019;94:1807–1813.
doi: 10.1016/j.mayocp.2019.03.027
Brandimarte G, Tursi A, Giorgetti GM. Changing trends in clinical form of celiac disease. Which is now the main form of celiac disease in clinical practice? Minerva Gastroenterol Dietol. 2002;48:121–130.
pubmed: 16489303
Rampertab SD, Pooran N, Brar P, Singh P, Green PHR. Trends in the presentation of celiac disease. Am J Med. 2006;119:355.e9–355.e14.
doi: 10.1016/j.amjmed.2005.08.044
Brar P, Kwon GY, Egbuna II, et al. Lack of correlation of degree of villous atrophy with severity of clinical presentation of coeliac disease. Dig Liver Dis. 2007;39:26–29.
doi: 10.1016/j.dld.2006.07.014
Thomas HJ, Ahmad T, Rajaguru C, Barnardo M, Warren BF, Jewell DP. Contribution of histological, serological, and genetic factors to the clinical heterogeneity of adult-onset coeliac disease. Scand J Gastroenterol. 2009;44:1076–1083.
doi: 10.1080/00365520903100473
Taavela J, Koskinen O, Huhtala H, et al. Validation of morphometric analyses of small-intestinal biopsy readouts in celiac disease. PLoS ONE.. 2013;8:e76163.
doi: 10.1371/journal.pone.0076163
Murray JA, Watson T, Clearman B, Mitros F. Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease. Am J Clin Nutr. 2004;79:669–673.
doi: 10.1093/ajcn/79.4.669
Zarkadas M, Cranney A, Case S, et al. The impact of a gluten-free diet on adults with coeliac disease: results of a national survey. J Hum Nutr Diet. 2006;19:41–49.
doi: 10.1111/j.1365-277X.2006.00659.x
Pekki H, Kurppa K, Mäki M, et al. Predictors and significance of incomplete mucosal recovery in celiac disease after 1 year on a gluten-free diet. Am J Gastroenterol. 2015;110:1078–1085.
doi: 10.1038/ajg.2015.155
Gidrewicz D, Trevenen CL, Lyon M, Butzner JD. Normalization time of celiac serology in children on a gluten-free diet. J Pediatr Gastroenterol Nutr. 2017;64:362–367.
doi: 10.1097/MPG.0000000000001270
Plevinsky JM, Greenley RN, Fishman LN. Self-management in patients with inflammatory bowel disease: strategies, outcomes, and integration into clinical care. Clin Exp Gastroenterol. 2016;9:259–267.
doi: 10.2147/CEG.S106302
Halpert A. Irritable bowel syndrome: patient-provider interaction and patient education. J Clin Med. 2018;7:3.
doi: 10.3390/jcm7010003
Paarlahti P, Kurppa K, Ukkola A, et al. Predictors of persistent symptoms and reduced quality of life in treated coeliac disease patients: a large cross-sectional study. BMC Gastroenterol. 2013;13:75.
doi: 10.1186/1471-230X-13-75
Romanos J, van Diemen CC, Nolte IM, et al. Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease. Gastroenterology. 2009;137:e3.
doi: 10.1053/j.gastro.2009.05.040
Bajor J, Szakács Z, Farkas N, et al. Classical celiac disease is more frequent with a double dose of HLA-DQB102: a systematic review with meta-analysis. PLoS ONE. 2019;14:e0212329.
doi: 10.1371/journal.pone.0212329